Hemato-oncology

Kite, a Gilead company, specializes in creating innovative cancer drugs. They focus on CAR T (Chimeric Antigen Receptor) cell treatments, available in Nederland, België en Luxemburg for the treatment of patients with specific types of blood cancers. Kite's manufacturing facility in Hoofddorp (Netherlands) is one of the locations in Kite's global Network. From Hoofddorp we supply cell therapy to European countries and beyond.

To update stakeholders from Belgium and Luxembourg on CAR T advancements, Kite has launched the Cell Therapy Hub, a portal dedicated to healthcare professionals.